Abstract
Searching for chemicals that will safely enhance transdermal drug delivery is a significant challenge. This study applies support vector regression (SVR) for the first time to estimating the optimal formulation design of transdermal hydrocortisone formulations. The aim of this study was to apply SVR methods with two different kernels in order to estimate the enhancement ratio of chemical enhancers of permeability. A statistically significant regression SVR model was developed. It was found that SVR with a nonlinear kernel provided the best estimate of the enhancement ratio for a chemical enhancer. Support vector regression is a viable method to develop predictive models of biological processes, demonstrating improvements over other methods. In addition, the results of this study suggest that a global approach to modelling a biological process may not necessarily be the best method and that a 'mixed-methods' approach may be best in optimising predictive models.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
